Comprehensive Cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic Cancer Patients Receiving Neoadjuvant Treatment

Kyong-Ah Yoon; Sang Myung Woo; Yun-Hee Kim; Sun-Young Kong; Min Kyoung Lee; Sung-Sik Han; Tae Hyun Kim; Woo Jin Lee; Sang-Jae Park

首页> 外文期刊>Gut and Liver >Comprehensive Cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic Cancer Patients Receiving Neoadjuvant Treatment

【24h】

Comprehensive Cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic Cancer Patients Receiving Neoadjuvant Treatment

机译：全面的癌症专家组测序确定了接受新辅助治疗的胰腺癌患者的遗传多样性和突变特征的变化

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background/AimsPancreatic ductal adenocarcinoma (PDA) is associated with an extremely poor prognosis. This study assessed the genetic diversity among patients with PDA and compared their mutational profiles before and after treatment.

机译：背景/目的胰腺导管腺癌（PDA）与极差的预后相关。这项研究评估了PDA患者的遗传多样性，并比较了治疗前后的突变情况。

著录项

来源
《Gut and Liver》 |2019年第6期|共7页
作者
Kyong-Ah Yoon; Sang Myung Woo; Yun-Hee Kim; Sun-Young Kong; Min Kyoung Lee; Sung-Sik Han; Tae Hyun Kim; Woo Jin Lee; Sang-Jae Park;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类内科学;
关键词
Pancreatic neoplasmsARID1AHistone-lysine N-methyltransferase;

机译：胰腺肿瘤ARID1A组蛋白赖氨酸N-甲基转移酶;

相似文献

外文文献
中文文献
专利

1. Proton therapy may allow for comprehensive elective nodal coverage for patients receiving neoadjuvant radiotherapy for localized pancreatic head cancers [J] . Richard Y. Lee, Romaine C. Nichols Jr, Soon N. Huh, Journal of Gastrointestinal Oncology . 2013,第4期

机译：质子疗法可为局部胰腺癌接受新辅助放疗的患者提供全面的选择性淋巴结覆盖
2. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets [J] . Witkiewicz Agnieszka K., McMillan Elizabeth A., Balaji Uthra, Nature Communications . 2015,第Apra期

机译：胰腺癌的全外显子测序确定了遗传多样性和治疗靶点
3. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets [J] . Agnieszka K. Witkiewicz, Elizabeth A. McMillan, Uthra Balaji, Nature Communications . 2015,第1期

机译：胰腺癌的全外显子测序确定了遗传多样性和治疗靶点
4. Technical Validation of a Next-Generation Sequencing Assay for Detecting Actionable Mutations in Patients with Gastrointestinal Cancer [C] . Simeen Malik, Sophie Ran Wang, Iam Beehuat Tan, International Molecular Medicine Tri-Conference. . 2016

机译：用于检测胃肠道癌患者可操作突变的下一代测序测定的技术验证
5. Characterization of Precancerous Mutations in Ulcerative Colitis-Associated Colorectal Cancer and High-Grade Serous Ovarian Cancer via Duplex Sequencing [D] . Baker, Kathryn Terese 2018

机译：溃疡性结肠炎相关大肠癌和高级别浆液性卵巢癌癌前突变的双重测序表征。
6. Comprehensive Cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic Cancer Patients Receiving Neoadjuvant Treatment [O] . Kyong-Ah Yoon, Sang Myung Woo, Yun-Hee Kim, 2019

机译：全面的癌症专家组测序确定了接受新辅助治疗的胰腺癌患者的遗传多样性和突变特征的变化
7. Evolutionary Analysis of Pre- and Post-treatment Molecular Diversity in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiation (CRT) and a KRAS Mutation-targeted Radiosensitizer [O] . S.C. Kamran, C. Eyler, J.K. Lennerz, 2020

机译：接受Neoadjuvant校长（CRT）和KRAS突变靶向放射敏剂的直肠癌患者前治疗前后分子多样性的进化分析

Comprehensive Cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic Cancer Patients Receiving Neoadjuvant Treatment

摘要

著录项

相似文献

相关主题

期刊订阅